Abstract
The micronucleus test (MNT) has been widely used in human biomonitoring due to its sensitivity in detecting DNA damage caused by genotoxic and cytotoxic agents. In patients with breast cancer, a significant increase in the frequency of micronuclei has been observed. Therefore, this project aims to analyze micronuclei using artificial intelligence (AI) in patients with breast cancer, optim…